Nova Patents
AT435873T

Anti-c2/c2a inhibitors of complement activation

Abstract

This record has no abstract on file.

Term

Term ended

Expired 23 March 2021, 5.5 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

70 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims8

Priority claims
DocumentOfficeKindDate
19142900United States of AmericaP
19142900United States of AmericaP
0109409United States of AmericaW
0109409United States of AmericaW
191429P–––
0109409–––
US20000191429P–––
WO2001US09409–––

Members70

Family members, oldest first
DocumentOfficeKind
CA2321140A1CanadaA1
WO9942133A1World Intellectual Property Organization (WIPO)A1
AU2870099AAustraliaA
EP1054693A1European Patent Office (EPO)A1
KR20010040585ARepublic of KoreaA
CN1298308AChinaA
WO0170818A1World Intellectual Property Organization (WIPO)A1
AU4941001AAustraliaA
US2001026928A1United States of AmericaA1
WO0170818A8World Intellectual Property Organization (WIPO)A8
JP2002503706AJapanA
US2002081293A1United States of AmericaA1
EP1265929A1European Patent Office (EPO)A1
AU762050B2AustraliaB2
NZ506920ANew ZealandA
EP1054693A4European Patent Office (EPO)A4
US2005196394A1United States of AmericaA1
US6956107B2United States of AmericaB2
US2005232920A1United States of AmericaA1
US6998468B2United States of AmericaB2
US7112327B2United States of AmericaB2
US2006240020A1United States of AmericaA1
CN100366293CChinaC
US2008193442A1United States of AmericaA1
US7439331B2United States of AmericaB2
EP1054693B1European Patent Office (EPO)B1
CN101298481AChinaA
AT412431TAustriaT
ATE412431T1AustriaT1
DE69939813D1GermanyD1
PT1054693EPortugalE
EP1054693B8European Patent Office (EPO)B8
EP2033659A2European Patent Office (EPO)A2
ES2317689T3SpainT3
SI1054693T1SloveniaT1
EP1265929B1European Patent Office (EPO)B1
AT435873TThis recordAustriaT
ATE435873T1AustriaT1
EP2033659A3European Patent Office (EPO)A3
DE60139189D1GermanyD1
PT1265929EPortugalE
DK1265929T3DenmarkT3
ES2329010T3SpainT3
JP4437192B2JapanB2
EP2277920A2European Patent Office (EPO)A2
US7927592B2United States of AmericaB2
US7943135B2United States of AmericaB2
US2011165169A1United States of AmericaA1
US2011195069A1United States of AmericaA1
US8124090B2United States of AmericaB2
US2012141480A1United States of AmericaA1
US8221756B2United States of AmericaB2
US8236317B2United States of AmericaB2
US2012251549A1United States of AmericaA1
EP2277920A3European Patent Office (EPO)A3
US2012322975A1United States of AmericaA1
US8383802B2United States of AmericaB2
US2013171155A1United States of AmericaA1
EP2033659B1European Patent Office (EPO)B1
SI2033659T1SloveniaT1
EP2277920B1European Patent Office (EPO)B1
US8765131B2United States of AmericaB2
US8911735B2United States of AmericaB2
US2015010569A1United States of AmericaA1
EP2848634A1European Patent Office (EPO)A1
CA2321140CCanadaC
EP3056516A1European Patent Office (EPO)A1
US2016264682A1United States of AmericaA1
EP3260467A1European Patent Office (EPO)A1
BRPI9909220B1BrazilB1